| Old Articles: <Older 29631-29640 Newer> |
|---|
 |
The Motley Fool
April 14, 2008
Toby Shute |
Get Fired Up About Tires! Titan International will begin manufacturing much-in-demand 57" and 63" tires for mining vehicles.   |
The Motley Fool
April 14, 2008
Brian Lawler |
MannKind Gets Smacked by Big Brother's Bad News Bad news for a competitor sinks MannKind shares. |
The Motley Fool
April 14, 2008
Brian Lawler |
A Little Delay Goes Away for CVT CV Therapeutics can move ahead, now that it has won marketing approval for its cardiac stress agent regadenoson. |
The Motley Fool
April 14, 2008
Toby Shute |
Sunset for Silicon Shortage Trina Solar bows out of its polysilicon plant plan. |
The Motley Fool
April 14, 2008
Brian Orelli |
Teva Gets What It Wants Teva persuades a court to order the FDA to award it a marketing exclusivity for generic Risperdal. |
The Motley Fool
April 14, 2008
Brian Lawler |
Not a Bad Quarter for Genentech Two of its top drugs see speedy growth, but investors don't seem ecstatic about Genentech's first-quarter financial results. |
The Motley Fool
April 14, 2008
Rich Duprey |
A Short Circuit at Blockbuster Is it a good idea for these two ailing businesses, Blockbuster and Circuit City, to join forces? |
The Motley Fool
April 14, 2008
Brian Orelli |
Stem Cells Show Off The FDA moves closer to setting up stem cell clinical trials, setting guidelines that put treatment safety first and foremost. |
The Motley Fool
April 14, 2008
Morgan Housel |
Wachovia's Bleeding Continues More capital infusions, more writedowns, more bad news. What's next for Wachovia? |
The Motley Fool
April 14, 2008
Anders Bylund |
3 Stocks That Missed the Mark These companies overpromised and underdelivered: Alcoa... Rite Aid... GE... |
| <Older 29631-29640 Newer> Return to current articles. |
